Subcellular Targeting Domains of Sphingomyelin Synthase 1 and 2 by Yeang, Calvin et al.
RESEARCH Open Access
Subcellular Targeting Domains of Sphingomyelin
Synthase 1 and 2
Calvin Yeang
1, Tingbo Ding
2, William J Chirico
1 and Xian-Cheng Jiang
1*
Abstract
Sphingomyelin synthase (SMS) sits at the crossroads of sphingomyelin (SM), ceramide, diacylglycerol (DAG)
metabolism. It utilizes ceramide and phosphatidylcholine as substrates to produce SM and DAG, thereby regulating
lipid messengers which play a role in cell survival and apoptosis. Furthermore, its product SM has been implicated
in atherogenic processes such as retention of lipoproteins in the blood vessel intima. There are two mammalian
sphingomyelin synthases: SMS1 and SMS2. SMS1 is found exclusively in the Golgi at steady state, whereas SMS2
exists in the Golgi and plasma membrane. Conventional motifs responsible for protein targeting to the plasma
membrane or Golgi are either not present in, or unique to, SMS1 and SMS2. In this study, we examined how SMS1
and SMS2 achieve their respective subcellular localization patterns. Brefeldin A treatment prevented SMS1 and
SMS2 from exiting the ER, demonstrating that they transit through the classical secretory pathway. We created
truncations and chimeras of SMS1 and SMS2 to define their targeting signals. We found that SMS1 contains a C-
terminal Golgi targeting signal and that SMS2 contains a C-terminal plasma membrane targeting signal.
Introduction
Sphingomyelin synthase is the last enzyme required for
de novo synthesis of sphingomyelin (SM). There are
three isoforms of sphingomyelin synthase (SMS): SMS1,
SMS2, and SMS related protein (SMSr). SMS1 and
SMS2 are true SM synthases in that they both utilize
phosphatidylcholine (PC) and ceramide to produce SM
and diacylglycerol (DAG). Although SMSr is highly
homologous to SMS1 and SMS2, it does not have SM
synthase activity [1]. Instead, it regulates cellular cera-
mide levels through synthesis of ceramide phosphoetha-
nolamine [2].
SMS1 and SMS2 are in a unique position to regulate
cellular SM, ceramide, and DAG levels. SM, in addition
to functioning as a structural component in biological
membranes, preferentially interacts with cholesterol to
form specialized membrane microdomains or “lipid rafts”
[3]. Both ceramide and DAG have been implicated in
numerous cell functions including growth, differentia-
tion, signal transduction, proliferation, and apoptosis
[4,5]. SMS1 and SMS2 differ, however, in their subcellu-
lar localization. At steady state, SMS1 resides in the
Golgi, while SMS2 is located in the Golgi and plasma
membrane. Flag-tagged SMS1[ 6 ]a n dV 5 - t a g g e dS M S 1
[1] are located in the Golgi while flag-tagged SMS2 [6]
and V5-tagged SMS2 [1] are found on the plasma mem-
brane and in the Golgi. Furthermore, SMS1 knockdown
in Hela cells attenuates SM synthase activity in the Golgi
while SMS2 siRNA treatment in Hela cells reduces SM
synthase activity in the plasma membrane [7]. These data
support the validity of using epitope tagged SMS to study
their localization patterns.
We examined how SMS1 and SMS2 are differentially
targeted using GFP fusion proteins. Analysis of the pri-
mary sequence of SMS1 and SMS2 (Additional File 1,
Figure S1), revealed that targeting of these proteins by
conventional sorting signals is unlikely. There is no well
characterized targeting signal which is unique to SMS1
or SMS2 explaining the difference in their localization
patterns. Although transmembrane domains can dictate
where a protein is targeted [8], SMS1, SMS2, and SMSr
are predicted to have very similar transmembrane
domains (Additional File 1, Figure S1), making that
mechanism less favorable. Our approach was to manipu-
late regions of amino acid sequence differences between
SMS1 and SMS2 and observe how those changes affect
their localization. Our findings show that the C-terminus
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Materials and Methods
Plasmid preparation
SMS1 (NM_147156), SMS2 (NM_028943), SMSr,
(NM_026283) were purchased from Open Biosystem. The
cDNA of SMS1 and SMS2 were cloned into pEGFP-C3
using PCR to amplify the coding region and simulta-
n e o u s l yt oi n t r o d u c ea5 ’ EcoR1 restriction site and 3’
BamH1 restriction site (Table 1). Due to the presence of a
BamH1 restriction site in the SMSr cDNA, SMSr was
cloned using PCR primers coding for a 5’ Hind III restric-
tion site and a 3’ EcoR1 restriction site. Truncation
mutants were similarly constructed using PCR and all
inserts had 5’ EcoR1 restriction site and 3’ BamH1 restric-
tion site unless otherwise noted. The primers used to gen-
erate these mutants are listed in the Table 1. The CD4
containing plasmid was a generous gift from Dr. Sreeniva-
san Ponnambalam from University of Leeds.
nS1/S2 and nS1/S2 plasmid preparation: A Sal1 restric-
tion site was introduced to SMS1 at amino codon 89 and,
correspondingly, codon 31 on SMS2 (Additional File 1,
F i g u r eS 1 )b ys i t ed i r e c t e dm utagenesis using a Kit from
Strategene. This resulted in a silent mutation of GTA to
GTC in both SMS1 and SMS2. By a similar method, a
Pst1 restriction site was introduced to within codons
131-132 on SMS1 and codons 72-73 on SMS2. This
resulted in a mutation of CTT CAG (SQ) to CTG CAG
(LQ) and a mutation of AAC AAG (KF) to CTG CAG
(LQ). Both vectors containing GFP-SMS1 and GFP-
SMS2 were digested with both Sal1 and Pst1. The region
flanked by Sal1 and Pst1 was excised from SMS1 and
ligated into the vector containing GFP-SMS2. The result-
ing chimera (nS1/S2) was cloned into pEGFP-C3. A chi-
mera of SMS1 with a swapped segment of SMS2 N-
terminus (nS2/S1) was created in the same fashion.
S1/cS2 and S2/cS1 plasmid preparation: A chimera
consisting of SMS1 from its N-terminus to amino acid
331 and SMS2 from amino acid 276 to its C-terminus
(S1/cS2) was cloned into pEGFP-C3. This was done by
site directed mutagenesis (Strategene), introducing an
AatII site into SMS1 and SMS2. Codons 331 and 332
GTG GTG (VV) was mutated to GAC GTG (VI) in
SMS1. Similarly, a chimera of SMS2 from its N-termi-
nus to amino acid 275 and SMS1 from amino acid 332
to its C-terminus (S2/cS1) was created. Silent mutations
of GTC ATC (VI) to GAC GTG (VI) were introduced
t oc o d o n s2 7 5a n d2 7 6o fS M S 2 .T oc o n s t r u c tt h ec h i -
meras, each mutant plasmid was digested with EcoR1,
AatII, and BamH1. The 5’ EcoR1 and AatII digestion
product of SMS1 was then ligated with the 3’ AatII and
B a m H 1d i g e s t i o np r o d u c to fS M S 2a n di n s e r t e di n t o
pEGFP-C3, creating S1/cS2. S2/cS1 was similarly
constructed.
Cell Culture and Transfections
Monolayer HeLa cells (from American Type Culture Col-
l e c t i o n )w e r eg r o w ni nD M E Ms u p p l e m e n tw i t h1 0 %
FBS, penicillin/streptomycin, and 2 mM glutamine. Cells
were grown to 50-60% confluency before transfection by
lipofectamine 2000 (Invitrogen). For fluorescent imaging
of GFP-tagged proteins, cells were seeded into 8 well
chamber slides (BD Falcon) and transfected with 200 ng
plasmid DNA in OptiMem (Invitrogen) for 24 hours. For
Western Blot analysis of GFP-tagged proteins, cells were
Table 1 Primers used for PCR cloning
Construct name Forward primer Reverse Primer
GFP SMS1 GGA ATT CCG AAG GAA GTG GTT TAT TGG TC CGG GAT CC T CAC CGG GAA TAC TTT CTG
GFP SMS2 GGA ATT CCG GAT ATC ATA GAG ACA GCA AAA C CGG GAT CCT CAG GTA GAC TTC TCA TTA TCC TC
GFP SMSr CCC AAG CTT CCC GCT GGT AGC CGA CGG AAT TCC GTC CAA TTA GTC TTT TCA TTA TTG
GFP SMS1 N120 GGA ATT CCG CCA GAA CTG GAG CGC CGG GAT CC T CAC CGG GAA TAC TTT CTG
GFP SMS1 N130 CGG AAT TCC GGA GTG GGG CAA GAC TTT TC CGG GAT CC T CAC CGG GAA TAC TTT CTG
GFP SMS2 N20 CGG GAT CC T CAG GTA GAC TTC TCA TTA TCC TC CGG GAT CCT CAG GTA GAC TTC TCA TTA TCC TC
GFP SMS2 N40 GGA ATT CCG AAA CCC AAG ACC TTA TCC CGG GAT CCT CAG GTA GAC TTC TCA TTA TCC TC
GFP SMS2 N60 GGA ATT CCG CAG ATT TCC ATG CCC AAC CGG GAT CCT CAG GTA GAC TTC TCA TTA TCC TC
GFP SMS2 N69 GGA ATT CCG AAC AAG TTT CCC CTG G CGG GAT CCT CAG GTA GAC TTC TCA TTA TCC TC
GFP SMS1ΔC4 GGA ATT CCG AAG GAA GTG GTT TAT TGG TC CGC GGA TCC CAG CCG GCT GTA TTT AA
GFP SMS1ΔC17 GGA ATT CCG AAG GAA GTG GTT TAT TGG TC CGC GGA TCC TGG CCA GGG GAA AGG
GFP SMS1ΔC27 GGA ATT CCG AAG GAA GTG GTT TAT TGG TC CGC GGA TCC AGG TAC AAT TCC TTG GAC
GFP SMS2ΔC32 GGA ATT CCG GAT ATC ATA GAG ACA GCA AAA C CGG GAT CCA AAG CAG CAA GGA ATT GAG
GFP SMS2ΔC67 GGA ATT CCG GAT ATC ATA GAG ACA GCA AAA C CGG GAT CCT CAC CGG GAA TAC TTT CTG C
SMS1 GFP GGA ATT CCG AAG GAA GTG GTT TAT TGG TC CGG GAT CCT GTG TCA TTC ACC AGC
SMS2 GFP GGA ATT CCG GAT ATC ATA GAG ACA GCA AAA C CGG GAT CCG GTA GAC TTC TCA TTA TCC TC
CD4 GFP GGA ATT CTT GCC ACC ATG AAC CGG GGA GTC C CGG GAT CCA ATG GGG CTA CAT GTC TT
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with 1000 ng plasmid DNA in OptiMem for 24 hours.
Brefeldin A treatment
Cells were transfected with GFP-SMS1 or GFP-SMS2 for
16 hours and then treated with brefeldin A (5 μg/ml) for
8 hrs. The cells were washed 3 times in PBS and then
fixed in 4% formaldehyde in PBS. In parallel, cells expres-
sing GFP-SMS1 or GFP-SMS2 and treated with brefeldin
A( 5μg/ml) for 8 hours were washed 6 times to remove
brefeldin A, incubated for 3 hours at 37 C and 5% CO2,
and then fixed.
Confocal microscopy and immunocytochemistry
HeLa cells expressing GFP-tagged proteins were fixed in
4% formaldehyde PBS and then viewed directly or sub-
jected to immunocytochemistry. For immunocytochemis-
try, cells were permeabilized with 0.1% Triton X-100 PBS
for 10 minutes and then blocked in 3% BSA PBS for 1
hour. Primary antibodies used include: rabbit anti-cal-
nexin (Abcam) 1:250, rabbit anti-TGN46 (Sigma) 1:250,
and rabbit anti-pan-Cadherin (Abcam) 1:250. Cells were
washed 3 times in PBS and incubated with anti-rabbit
IgG conjugated to Alexa Fluor 540 for 1 hour. After
three washes, TO-PRO 3 (Invitrogen), diluted 1:1000 in
PBS, was added to cells to stain the nuclei. Slides were
mounted in VectaShield (Vector Labs) and analyzed on a
confocal microscope (Bio-Rad Radiance 2000) using 488
nm, 543 nm, and 638 nm excitation and a 40 X objective
lens. Wheat germ agglutinin (WGA)- Alexa Fluor 647
(1:1000) was added to live cells prior to fixation to mini-
mize intracellular staining.
Results
Localization of GFP-SMS1 and GFP-SMS2
GFP expressed in mammalian cells is primarily cytosolic
and widely used to study targeting signals. We prepared
GFP fusion proteins of SMS1, SMS2, and SMSr to iden-
tify the domain(s) that are responsible for their sorting.
GFP-SMS1 was co-localized with trans-Golgi network
peptide 46 (TGN46) to the Golgi apparatus (Figure 1A)
while GFP-SMS2 was localized to the Golgi apparatus
and plasma membrane (Figure 1B). GFP-SMSr had a
unique subcellular localization pattern, co-localizing with
calnexin in the endoplasmic reticulum (ER) (Additional
File 1, Figure S2). All fusion proteins were expressed at
the expected molecular size, as determined by Western
Blot (Additional File 1, Figure S3).
Brefeldin A inhibits the sorting of SMS1 and SMS2
The fungal metabolite brefeldin A (BFA) inhibits antero-
grade vesicular transport from the ER to Golgi [9] and
thereby leads to accumulation of proteins which transit
through the classical secretory pathway in the ER.
Brefeldin A reversibly blocks ER to Golgi transfer
through inhibiting ARF, a small GTPase responsible for
vesicle formation [10]. We treated HeLa cells expressing
GFP-SMS1 or GFP-SMS2 with BFA to determine if they
are sorted via the classical secretory pathway. CD4-GFP,
an integral membrane protein which is sorted to the
plasma membrane via the classical secretory pathway
[11], was used as a control. In BFA-treated cells, GFP-
SMS1 (Figure 2A), GFP-SMS2 (Figure 2B), and CD4-GFP
(Figure 2C) localized to the ER. In contrast, GFP localiza-
tion was unaffected by BFA (not shown). BFA can be
removed from cells by washing, thereby restoring trans-
port through the pathway. After removing BFA from
cells expressing GFP-SMS1, GFP-SMS2 or CD4-GFP, the
wild-type localization pattern of each protein was rescued
(Figure 2D-F). Together, these results suggest that SMS1
and SMS2 are sorted through the classical secretory
pathway.
Probing SMS1’s and SMS2’s N-terminus for subcellular
targeting signals
We examined the N-terminus of SMS1 and SMS2 for
sorting signals because this region contained the most
sequence differences and might be responsible for the
different localization patterns. Truncation of 120 amino
acids from the SMS1 N-terminus (GFP-SMS1 N120) and
truncation of 40 amino acids from the SMS2 N-terminus
(GFP-SMS2 N40) did not affect the localization pattern
of these proteins (Additional File 1, Table S1). However,
truncation of 130 amino acids from SMS1 (GFP-SMS1
N130) and 60 amino acids from SMS2 (GFP-SMS2 N60)
resulted in an ER and preinuclear localization pattern
(Figure 3 and Additional File 1, Table S1).
It was possible that these truncations disrupted or
removed a signal that was important for the normal tar-
geting of SMS1 and SMS2. However, we also considered
the possibility that these truncations can lead to misfold-
ing of the protein and thereby induce chaperone
mediated retention in the ER. Unlike truncations, domain
exchange better preserves the overall architecture of the
protein. Therefore, to further study the N-terminus of
SMS1 and SMS2, we created chimeras by swapping
regions of the N-terminus between SMS1 and SMS2.
The region in SMS1 extends from amino acid 121 to 131
(where sequence homology with SMS2 resumes). Simi-
larly, the region in SMS2 extends from amino acid 61 to
77. A chimera of SMS1 with a portion of SMS2’sN - t e r -
minus (nS2/S1) and one of SMS2 containing a portion of
SMS1’s N-terminus (nS1/S2) were created. nS2/S1 loca-
lized to the Golgi only (Figure 4A), as does full length
SMS1 (Figure 1A), while nS1/S2 localized to the Golgi
and plasma membrane (Figure 4B), as does full length
SMS2 (Figure 1B). Therefore, the N-terminus of SMS1
does not contain a Golgi targeting signal and the
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brane targeting signal.
The C-terminus of SMS1 contains a Golgi retention signal
and C-terminus of SMS2 contains a plasma membrane
targeting signal
We also examined the C-terminus of SMS1 and SMS2
for sorting signals because they contain several amino
acid sequence differences that might be responsible for
differences in their subcellular localization. Using the
same approach described in the previous section, we
created chimeras by exchanging the C-terminus of
SMS1 and SMS2 yielding S1/cS2 and S2/cS1. S1/cS2 is
a GFP fusion composed of residues 1-331 of SMS1 and
residues 276-356 of SMS2. S2/cS1 is a GFP fusion com-
posed of residues 1-275 of SMS2 and residues 332-414
of SMS1. S1/cS2 localized to the plasma membrane and
Golgi (Figure 5A), which matches the wild type SMS2
pattern. S2/cS1 localized to the Golgi only (Figure 5B),
mimicking wild type SMS1. These results suggest that
SMS1 possesses a Golgi retention or retrieval signal in
the C-terminus and that SMS2 has a plasma membrane
targeting signal in its C-terminus.
To better define the signal, we created C-terminal
truncation mutants of SMS1 and SMS2. SMS2 localized
to both the plasma membrane and Golgi when its most
distal 32 amino acids were removed (S2ΔC32, Figure
5C). In contrast, SMS2 localized only to the Golgi when
67 amino acids from its C-terminus were removed
(S2ΔC67, Figure 5D). Deleting the 4 most distal amino
acids from SMS1 did not change its native localization
pattern (S1ΔC 4 ,F i g u r e5 E ) .H o w e v e r ,d e l e t i n g1 7
Figure 1 Localization of GFP-SMS1 and 2 fusion proteins. Confocal microscopy showing co-localization of TGN46 (Golgi marker) and Wheat
Germ Agglutinin (WGA, plasma membrane marker) with GFP-SMS1 (A) and GFP-SMS2 (B). Schematics depict predicted transmembrane (TM)
domains in SMS1 and SMS2. TOPRO is a marker for nucleus.
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Page 4 of 9Figure 2 BFA blocks sorting of SMS1 and 2. HeLa cells expressing GFP-SMS1 (A and D), GFP-SMS2 (B and E), CD4-GFP (C and F) were treated
with BFA (5 μg/ml) for 8 hours (A-C). The cells were washed 6 times with growth media to remove BFA and allowed to recover for 3 h (D-F).
Images were obtained using confocal microscopy. Calnexin is an ER marker, TGN46 is a Golgi marker, and Wheat Germ Agglutinin (WGA) is a
plasma membrane marker.
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Page 5 of 9(S1ΔC17, Figure 5F) or 27 amino acids (S1ΔC27, Figure
5G) from the C-terminus of SMS1 resulted in a plasma
membrane and Golgi targeted protein. These data sug-
gest that SMS1 has a Golgi retention or retrieval
sequence between amino acid residues 332 and 410.
Discussion
In this study, we found for the first time that SMS1 con-
tains a C-terminal Golgi targeting signal, while SMS2
contains a C-terminal plasma membrane targeting sig-
nal. The difference in cellular localization may reflect
the distinct functions of SMS1 and SMS2. Given their
role as a potential regulator of diseases, these findings,
coupled with our homology modeling of SMS1 and
SMS2 [6], will be useful for developing SMS1- and
SMS2-specific inhibitors.
SMS1 and SMS2 transit through the classical secretory
pathway and their respective C-terminal tails determine
the fate of localization along the secretory pathway.
Recently, Vacaru et al. [2] demonstrated that truncation
of the SMSr N-terminus results in Golgi localization of
the protein, suggesting that SMSr also enters the classi-
cal secretory pathway.
Proteins destined for the classical secretory pathway
generally contain an N-terminal ER signal sequence
which facilitates the proteins co-translational insertion
into the ER [12]. Although a signal sequence is absent
in SMS1 and SMS2, not all proteins which enter the ER
have a signal sequence. Examples are multipass trans-
membrane proteins such as opsin, rhodopsin and other
G-protein coupled receptors (GPCRs)[13]. Insertion of
opsin into the ER membrane is guided solely by multiple
Figure 3 Localization of N-terminal truncation mutants of SMS1 and SMS2. HeLa cells expressing GFP-SMS1 N130 (A) and GFP-SMS2 N60
(B). The organelle markers used were calnexin (ER) and TOPRO 3 (nucleus). The images were obtained using confocal microscopy.
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within the protein and dependent on SRP [14]. Follow-
ing incorporation into the ER, these proteins can be
further sorted via vesicular transport to organelles
including the Golgi, plasma membrane (as described
below), lysosome, and endosome. It is likely that each of
the predicted hydrophobic transmembrane domains
within SMS1 and SMS2 act as internal start- and stop-
transfer sequences.
Once inside the classical secretory pathway, the C-ter-
minus of SMS1 and SMS2 direct the protein to its
steady state location. A chimera of SMS2 containing the
SMS1 C-terminus is sorted to the Golgi, while a chi-
mera of SMS1 containing the SMS2 C-terminus is
released to the plasma membrane. We demonstrated
that the SMS1 C-terminus contains a Golgi targeting
signal which can be disrupted by truncating its last 17
amino acids. In the absence of the Golgi targeting signal,
it’s likely that SMS1 proceeds through the secretory
pathway to reach the plasma membrane. Bos et al. [15]
have shown that TGN 38, a Golgi targeted protein, is
localized to the plasma membrane if its Golgi targeting
signal is disrupted. Similarly, SMS1 contains a retention
or retrieval signal which prevents it from being localized
to the plasma membrane. SMS2 contains a C-terminal
plasma membrane targeting signal which can be dis-
rupted by truncating the last 67, but not 32 amino
acids. In the absence of this signal, SMS2 is found in
the Golgi, which suggests the existence of a Golgi tar-
geting sequence which is masked by the presence of the
last 67 amino acids.
Tani and Kuge reported that SMS2 is specifically pal-
mitoylated on four serine residues at the C-terminus,
and this palmitoylation is involved in SMS2 plasma
membrane localization [16]. We observed that S2ΔC32
(which still contains palmitoylation sites C331, C332)
does not affect plasma membrane localization while
S2ΔC67 (which has no palmitoylation sites) fails to loca-
lize to the plasma membrane (Figure 5C and 5D). These
findings are consistent with the role of palmitoylation in
targeting SMS2 to the plasma membrane. However, the
C331, C332, C343, and C348 quadruple mutant of
SMS2 was found to have less plasma membrane locali-
zation compared to WT SMS2 [16] while S2ΔC67 is not
found on the plasma membrane (Figure 5D), suggesting
that the SMS2 C-terminus contains multiple signals
important for plasma membrane targeting. However, we
could not rule out the possibility that the half life of
Figure 4 Localization of SMS1 and SMS2 N-terminal chimeras. HeLa cells transfected with GFP-nS2/S1 (A) or GFP-nS1/S2 (B). The organelle
markers were TGN46 (trans-Golgi) and WGA (plasma membrane). Images were obtained using confocal microscopy.
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Page 7 of 9Figure 5 Localization of SMS1 and SMS2 C-terminal chimeras and mutants. Confocal images of HeLa cells transfected with A) GFP-S1/cS2,
B) GFP-S2/cS1, C) GFP-S2ΔC32, D) GFP-S2ΔC67, E) GFP-S1ΔC4, F) GFP-S1ΔC17, and G) GFP-S1ΔC27. Organelle markers used were TGN46 (Golgi)
and WGA (plasma membrane).
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decreased or removal of the SMS2 C-terminal segment
produces a mutant which is more susceptible to degra-
dation at the plasma membrane and therefore is predo-
minantly located in the Golgi at steady state. We believe
that this is an interesting issue which deserves further
study.
In this study, which focuses on the subcellular localiza-
tion of SMS1 and SMS2, we utilized GFP-tagged SMS,
which can be directly visualized in the cell using confocal
microscopy. Although it is possible that GFP, as an N-
terminal fusion protein, may influence sorting of these
proteins, it is unlikely based on existing evidence. SMS1
containing a C-terminal Flag tag [6] or C-terminal V5 tag
[1] localize to the Golgi, as does GFP-SMS1. Similarly,
SMS2 containing a C-terminal Flag tag [6] or C-terminal
V5 tag [1] localize to the Golgi and plasma membrane, as
does GFP-SMS2. GFP is a widely used tool to study pro-
tein sorting, and it is justifiably used to exam the subcel-
lular targeting of SMS1 and SMS2.
Our results shed new light on the signals that guide
SMS1 and SMS2 to their steady state sub-cellular com-
partments. Further study manipulating the localization
of these enzymes may reveal the importance of subcellu-
lar compartment-specific SM synthesis.
Additional material
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